Medivolve Inc.
Medivolve Inc. MEDV.NE Peers
See (MEDV.NE) competitors and their performances in Stock Market.
Stock Comparison
MEDV.NE vs TMO.NE Comparison
MEDV.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDV.NE stands at 810576.00. In comparison, TMO.NE has a market cap of 213.83B. Regarding current trading prices, MEDV.NE is priced at $0.03, while TMO.NE trades at $15.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDV.NE currently has a P/E ratio of -0.09, whereas TMO.NE's P/E ratio is 23.63. In terms of profitability, MEDV.NE's ROE is +0.09%, compared to TMO.NE's ROE of N/A. Regarding short-term risk, MEDV.NE is more volatile compared to TMO.NE. This indicates potentially higher risk in terms of short-term price fluctuations for MEDV.NE.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMO.NE | $15.12 | +0.40% | 213.83B | 23.63 | $0.64 | N/A |
| EDT.TO | $0.87 | +4.82% | 248.05M | -17.40 | -$0.05 | N/A |
| AKU.TO | $0.53 | N/A | 45.15M | -0.14 | -$3.80 | N/A |
| SONA.CN | $0.30 | +9.09% | 32.50M | -10.00 | -$0.03 | N/A |
| BUX.CN | $0.28 | N/A | 25.45M | -14.00 | -$0.02 | N/A |
| IZO.CN | $0.24 | N/A | 15.85M | -6.00 | -$0.04 | N/A |
| SZLS.TO | $0.04 | N/A | 4.94M | -0.25 | -$0.16 | N/A |
| MEDV.NE | $0.03 | +50.00% | 810576.00 | -0.09 | -$0.35 | N/A |
| SCRN.CN | N/A | N/A | N/A | N/A | -$0.06 | N/A |